Montelukast vs Rabeprazole
Montelukast vs Rabeprazole: Overview
This comparison examines the pharmacological differences between Montelukast and Rabeprazole.
Mechanism of Action
Montelukast: Selective leukotriene D4 receptor antagonist.
Rabeprazole: Proton pump inhibitor irreversibly inhibiting gastric H+/K+-ATPase with faster onset than omeprazole.
Pharmacokinetics
Half-life: Montelukast β 2.7-5.5 hours; Rabeprazole β 1-2 hours.
Chemical Properties
Molecular Formula: Montelukast β C35H36ClNO3S; Rabeprazole β C18H21N3O3S.
Molecular Weight: Montelukast β 586.1800 g/mol; Rabeprazole β 359.4440 g/mol.
Type: Montelukast β Small molecule; Rabeprazole β Small molecule.